Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and CytoDyn Inc. (OTCQB: CYDY) ...
(RTTNews) - CytoDyn Inc. (CYDY.OB) has announced positive results from its preclinical studies in collaboration with SMC Laboratories, demonstrating the potential of leronlimab to reverse liver ...
(RTTNews) - CytoDyn Inc. (CYDY) has received dedicated funding from a compassionate benefactor to initiate an Expanded Access Program (EAP) for patients with triple-negative breast cancer, marking a ...
29d
CytoDyn Inc.
CytoDyn Inc. Annual stock financials by MarketWatch. View the latest CYDY financial statements, income statements and financial ratios.
CFO Robert E. Hoffman to deliver company presentation on May 18 at 10 a.m. PT VANCOUVER, Washington, May 15, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a ...
VANCOUVER, Washington, April 23, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized ...
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results